vs
Side-by-side financial comparison of AeroVironment Inc (AVAV) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $472.5M, roughly 1.0× AeroVironment Inc). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -3.6%, a 10.4% gap on every dollar of revenue. On growth, AeroVironment Inc posted the faster year-over-year revenue change (181.9% vs -1.7%). Over the past eight quarters, AeroVironment Inc's revenue compounded faster (59.1% CAGR vs -0.1%).
AeroVironment, Inc., also known as AV, is an American defense technology company headquartered in Arlington, Virginia that designs and manufactures autonomous systems, counter-UAS systems, and space systems. The company was founded in 1971 by Paul B. MacCready Jr., a designer of human-powered aircraft. The company provides the US Department of Defense and foreign militaries with small and medium-sized drones—notably the Raven, Switchblade, Wasp, and Puma. Through its acquisition of BlueHalo i...
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
AVAV vs MD — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $472.5M | $493.8M |
| Net Profit | $-17.1M | $33.7M |
| Gross Margin | 22.0% | — |
| Operating Margin | -6.4% | 9.9% |
| Net Margin | -3.6% | 6.8% |
| Revenue YoY | 181.9% | -1.7% |
| Net Profit YoY | -875.1% | 10.5% |
| EPS (diluted) | $-0.34 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $472.5M | $493.8M | ||
| Q3 25 | $454.7M | $492.9M | ||
| Q2 25 | $275.1M | $468.8M | ||
| Q1 25 | $167.6M | $458.4M | ||
| Q4 24 | $188.5M | $502.4M | ||
| Q3 24 | $189.5M | $511.2M | ||
| Q2 24 | $197.0M | $504.3M | ||
| Q1 24 | $186.6M | $495.1M |
| Q4 25 | $-17.1M | $33.7M | ||
| Q3 25 | $-67.4M | $71.7M | ||
| Q2 25 | $16.7M | $39.3M | ||
| Q1 25 | $-1.8M | $20.7M | ||
| Q4 24 | $7.5M | $30.5M | ||
| Q3 24 | $21.2M | $19.4M | ||
| Q2 24 | $6.0M | $-153.0M | ||
| Q1 24 | $13.9M | $4.0M |
| Q4 25 | 22.0% | — | ||
| Q3 25 | 20.9% | — | ||
| Q2 25 | 36.5% | — | ||
| Q1 25 | 37.7% | — | ||
| Q4 24 | 39.1% | — | ||
| Q3 24 | 43.0% | — | ||
| Q2 24 | 38.4% | — | ||
| Q1 24 | 36.1% | — |
| Q4 25 | -6.4% | 9.9% | ||
| Q3 25 | -15.2% | 13.8% | ||
| Q2 25 | 5.0% | 12.8% | ||
| Q1 25 | -1.8% | 7.0% | ||
| Q4 24 | 3.7% | 7.8% | ||
| Q3 24 | 12.2% | 6.6% | ||
| Q2 24 | 3.0% | -31.3% | ||
| Q1 24 | 7.7% | 3.2% |
| Q4 25 | -3.6% | 6.8% | ||
| Q3 25 | -14.8% | 14.5% | ||
| Q2 25 | 6.1% | 8.4% | ||
| Q1 25 | -1.0% | 4.5% | ||
| Q4 24 | 4.0% | 6.1% | ||
| Q3 24 | 11.2% | 3.8% | ||
| Q2 24 | 3.1% | -30.3% | ||
| Q1 24 | 7.4% | 0.8% |
| Q4 25 | $-0.34 | $0.40 | ||
| Q3 25 | $-1.44 | $0.84 | ||
| Q2 25 | $0.59 | $0.46 | ||
| Q1 25 | $-0.06 | $0.24 | ||
| Q4 24 | $0.27 | $0.37 | ||
| Q3 24 | $0.75 | $0.23 | ||
| Q2 24 | $0.18 | $-1.84 | ||
| Q1 24 | $0.50 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $588.5M | $375.2M |
| Total DebtLower is stronger | $747.5M | $570.5M |
| Stockholders' EquityBook value | $4.4B | $865.9M |
| Total Assets | $5.6B | $2.2B |
| Debt / EquityLower = less leverage | 0.17× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $588.5M | $375.2M | ||
| Q3 25 | $685.8M | $340.1M | ||
| Q2 25 | $40.9M | $224.7M | ||
| Q1 25 | $47.0M | $99.0M | ||
| Q4 24 | $69.0M | $229.9M | ||
| Q3 24 | $81.2M | $103.8M | ||
| Q2 24 | $73.3M | $19.4M | ||
| Q1 24 | $107.7M | $8.0M |
| Q4 25 | $747.5M | $570.5M | ||
| Q3 25 | $747.5M | $577.2M | ||
| Q2 25 | $30.0M | $583.9M | ||
| Q1 25 | $25.0M | $590.5M | ||
| Q4 24 | $15.0M | $597.1M | ||
| Q3 24 | $17.5M | — | ||
| Q2 24 | $28.0M | — | ||
| Q1 24 | $40.0M | — |
| Q4 25 | $4.4B | $865.9M | ||
| Q3 25 | $4.4B | $890.7M | ||
| Q2 25 | $886.5M | $833.8M | ||
| Q1 25 | $861.1M | $789.2M | ||
| Q4 24 | $858.4M | $764.9M | ||
| Q3 24 | $845.5M | $732.5M | ||
| Q2 24 | $822.7M | $706.5M | ||
| Q1 24 | $813.0M | $856.2M |
| Q4 25 | $5.6B | $2.2B | ||
| Q3 25 | $5.6B | $2.2B | ||
| Q2 25 | $1.1B | $2.1B | ||
| Q1 25 | $1.0B | $2.0B | ||
| Q4 24 | $1.0B | $2.2B | ||
| Q3 24 | $999.2M | $2.1B | ||
| Q2 24 | $1.0B | $2.0B | ||
| Q1 24 | $980.3M | $2.2B |
| Q4 25 | 0.17× | 0.66× | ||
| Q3 25 | 0.17× | 0.65× | ||
| Q2 25 | 0.03× | 0.70× | ||
| Q1 25 | 0.03× | 0.75× | ||
| Q4 24 | 0.02× | 0.78× | ||
| Q3 24 | 0.02× | — | ||
| Q2 24 | 0.03× | — | ||
| Q1 24 | 0.05× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-45.1M | $114.1M |
| Free Cash FlowOCF − Capex | $-55.9M | — |
| FCF MarginFCF / Revenue | -11.8% | — |
| Capex IntensityCapex / Revenue | 2.3% | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $-240.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-45.1M | $114.1M | ||
| Q3 25 | $-123.7M | $137.3M | ||
| Q2 25 | $-264.0K | $137.2M | ||
| Q1 25 | $-25.8M | $-117.5M | ||
| Q4 24 | $-3.6M | $133.0M | ||
| Q3 24 | $28.4M | $91.8M | ||
| Q2 24 | $-11.7M | $107.0M | ||
| Q1 24 | $52.6M | $-125.2M |
| Q4 25 | $-55.9M | — | ||
| Q3 25 | $-146.5M | — | ||
| Q2 25 | $-8.8M | — | ||
| Q1 25 | $-29.6M | — | ||
| Q4 24 | $-8.7M | — | ||
| Q3 24 | $22.9M | — | ||
| Q2 24 | $-20.8M | — | ||
| Q1 24 | $48.8M | — |
| Q4 25 | -11.8% | — | ||
| Q3 25 | -32.2% | — | ||
| Q2 25 | -3.2% | — | ||
| Q1 25 | -17.7% | — | ||
| Q4 24 | -4.6% | — | ||
| Q3 24 | 12.1% | — | ||
| Q2 24 | -10.5% | — | ||
| Q1 24 | 26.1% | — |
| Q4 25 | 2.3% | — | ||
| Q3 25 | 5.0% | — | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 2.3% | — | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | 2.9% | — | ||
| Q2 24 | 4.6% | — | ||
| Q1 24 | 2.0% | — |
| Q4 25 | — | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | -0.02× | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | -0.48× | 4.36× | ||
| Q3 24 | 1.34× | 4.72× | ||
| Q2 24 | -1.93× | — | ||
| Q1 24 | 3.79× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVAV
| Services | $130.2M | 28% |
| Cost Plus | $95.8M | 20% |
| Uncrewed Aircraft Systems | $89.8M | 19% |
| Space And Directed Energy | $53.2M | 11% |
| Non U.s.Government | $42.2M | 9% |
| TM | $31.9M | 7% |
| Other | $30.7M | 7% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
